Abstract: The pharmaceutical composition provided by the present invention comprises at least one pharmaceutically acceptable carrier, and an active ingredient including an artificially synthesized peptide comprises: (A) an amino acid sequence constituting a cell-penetrating peptide and (B) an amino acid sequence constituting the signal peptide in amyloid precursor protein (APP) or an N-terminal partial amino acid sequence or C-terminal partial amino acid sequence from the amino acid sequence constituting that signal peptide.
Abstract: The pharmaceutical composition provided by the present invention comprises at least one pharmaceutically acceptable carrier, and an active ingredient including an artificially synthesized peptide comprises: (A) an amino acid sequence constituting a cell-penetrating peptide and (B) an amino acid sequence constituting the signal peptide in amyloid precursor protein (APP) or an N-terminal partial amino acid sequence or C-terminal partial amino acid sequence from the amino acid sequence constituting that signal peptide.
Abstract: The object is to provide an amorphous inorganic anion exchanger having excellent anion exchangeability and suppressed corrosivity toward metals and to provide a production process that can produce an amorphous bismuth compound having excellent anion exchangeability and suppressed corrosivity toward metals. The amorphous inorganic anion exchanger of the present invention is represented by Formula (1) and has an average primary particle size observed with an electron microscope of at least 1 nm but no greater than 500 nm and an NO3 content of no greater than 1 wt % of the whole. The process for producing an amorphous bismuth compound of the present invention includes a precipitate formation step of forming a precipitate by subjecting an acidic aqueous solution containing trivalent Bi ions to a temperature in the range of higher than 0° C. but less than 20° C.
Type:
Application
Filed:
June 13, 2013
Publication date:
November 12, 2015
Applicant:
TOAGOSEI CO., LTD.
Inventors:
Kentarou MIYAMURA, Tomohisa IINUMA, Yasuharu ONO
Abstract: Disclosed is an electrolysis method, whereby sodium chloride concentration of an aqueous caustic soda solution formed through electrolysis in a two-chamber ion-exchange membrane sodium chloride electrolytic cell, which is equipped with a gas diffusion electrode as a cathode and divided into an anode chamber containing an anode and a cathode gas chamber containing the cathode that are partitioned by an ion-exchange membrane, is lowered. In a two-chamber ion-exchange membrane electrolytic cell (1) using a gas diffusion electrode (7), electrolysis is performed while reducing the pressure difference between the liquid pressure in the anode chamber and the gas pressure in the cathode gas chamber, i.e.
Abstract: The present invention is a method for producing a polysiloxane represented by formula (1), which includes a condensation step wherein a hydrolysis/polycondenzation of a starting material monomer that forms a constituent unit is carried out in a reaction solvent that contains at least one alcohol that is selected from among secondary alcohols having 4-6 carbon atoms and tertiary alcohols having 4-6 carbon atoms. The method for producing a polysiloxane of the present invention suppresses problems such as gelation that occurs during the production, and increase in the molecular weight or gelation that occurs during storage after the production or the like.
Abstract: Provided is an adhesive composition which can form a cured product that is high in shear adhesion strength, peel adhesion strength and impact adhesion strength and particularly is excellent in cold/hot cycle resistance of adhesion strength. The adhesive composition comprises (a) a 2-cyanoacrylic acid ester, (b) a high molecular-weight component compatible with 2-cyanoacrylic acid ester, (c) a multifunctional 2-cyano-3-vinylacrylic acid ester, and (d) an onium salt represented by the following general formula (1): C+A???(1) wherein, C+ represents an onium cation and A? represents an anion which does not substantially initiate polymerization of the 2-cyanoacrylic acid ester, and the components (a)-(d) are contained in predetermined amounts.
Abstract: The current invention is to provide an oxygen gas diffusion cathode for brine electrolysis which reduces an initial electrolysis voltage and is excellent in the durability against short-circuit, and an electrolytic cell and an electrolytic method using the same. The oxygen gas diffusion cathode for brine electrolysis includes a gas diffusion layer 13 and a reaction layer 14 on one surface of an electro-conductive substrate 12, and an electro-conductive layer 15 on the opposite surface thereof. The present oxygen gas diffusion cathode reduces the resistance of the electro-conductive substrate 12 and supplies uniform current by mounting the electro-conductive layer 15.
Abstract: Disclosed is a method for producing chloropolysilane by which the yield of a fluid reaction to produce the chloropolysilane is improved while blockage in a reactor caused by attachment of higher-order silicon chloride as a by-product is prevented. In producing the chloropolysilane by reacting fluidized silicon particles or silicon alloy particles with a chlorine gas, an outlet filter is provided, upstream from a product outlet that releases a reaction product, above the area in which the silicon particles or silicon alloy particles are fluidized inside a reaction tank. The outlet filter prevents fine particles blown up by fluidization from flowing out of the reaction tank through the product outlet. A temperature of the outlet filter is set in a range of 210 to 350° C.
Abstract: The purpose of the invention is to provide: a composition for an organic semiconductor insulating film, which is capable of forming an insulating film that exhibits excellent hydrophobicity and smoothness of the surface, while having excellent electrical stability; and an organic semiconductor insulating film obtained by using the composition for an organic semiconductor insulating film. The present composition contains a polysiloxane and an organic polymer compound. The polysiloxane is a polyhedral silsesquioxane having an oxetanyl group and/or an oxetanyl group containing silicon compound represented by the following formula (1). In the formula (1), each of R1-R3 independently represents a monovalent organic group (provided that at least one of R1-R3 is a monovalent organic group having an oxetanyl group); and each of v, w, x and y independently represents 0 or a positive number (provided that w and at least one of v, x and y are positive numbers).
Abstract: A method for manufacturing at least one kind of eukaryotic cells or a biosynthetic substance derived from the eukaryotic cells by proliferating the cells, which includes preparing an artificially synthesized peptide for promoting proliferation of the at least one kind of eukaryotic cells, incubating the eukaryotic cells in a culture medium, and adding the synthesized peptide at least once to the culture medium during the incubation process. The synthesized peptide includes an amino acid sequence selected from SEQ ID NOS: 1 to 18, and an amino acid sequence selected from SEQ ID NOS: 19 to 97.
Abstract: The present invention provides a latent fingerprint detection, method that is to handle and is capable of clearly detecting a latent fingerprint, and a heating evaporation device for detecting a latent fingerprint and a latent fingerprint detection apparatus which are capable of detecting a clear latent fingerprint by a one-time operation by heating a chemical agent at high temperatures in a short time, as well as a composition for detecting a latent fingerprint. This latent fingerprint detection method includes a heating step of heating a chemical agent to be gasified by heating so as to attach to a latent fingerprint on a specimen, and an exposure step of exposing the specimen having the latent fingerprint attached thereto to the atmosphere of the gasified chemical agent. The chemical agent is a mixture of a 2-cyanoacrylic acid ester polymer and a dye.
Type:
Application
Filed:
October 11, 2013
Publication date:
September 3, 2015
Applicants:
TOAGOSEI, CO., LTD., EARTH CHEMICAL CO., LTD.
Abstract: Provided is a method for adjusting the balance of TNF-R1 and TNF-R2 in cells present at a target organ, tissue or site. In the adjustment method provided, when increasing the relative presence of TNF-R2 compared to the presence of TNF-R1 in the cells, a synthetic peptide is supplied to the cells, with the peptide being essentially made of at a TNF-R1 signal peptide motif or a modified amino acid sequence thereof; and when decreasing the relative presence of TNF-R2 compared to the presence of TNF-R1 in the cells, a synthetic peptide is supplied to the cells, with the peptide being essentially made of a TNF-R2 signal peptide motif or a modified amino acid sequence thereof.
Abstract: A chlorination reaction can be carried out at a relatively low temperature by heating a mixture of granular metallic silicon and metallic copper or a copper compound in an inert atmosphere even when the metallic silicon has a high purity and does not contain aluminum and titanium and that chloropolysilane of high purity can be obtained by further adding metallic silicon as needed after the chlorination reaction is started.
Abstract: The filler of the present invention is characterized by comprising hexagonal phosphate particles represented by formula (1) and having a median diameter of 0.05 ?m or more and 10 ?m or less based on the volume as measured by a laser diffraction particle size analyzer. The method for producing a hexagonal phosphate of the present invention is characterized by comprising the steps of: mixing a tetravalent laminar metal phosphate, a compound of at least one divalent metal selected from the group consisting of alkaline earth metals, Zn, Cu, Ni and Mn, and an m-valent metal compound to obtain a mixture; and calcinating the mixture to obtain a hexagonal phosphate represented by formula (1). AxByCz(PO4)3.
Abstract: An acrylic acid-based polymer composition of the present invention is obtained using a hypophosphorous acid compound in an amount of 0.5 to 4.5 parts by mass based on 100 parts by mass of a total of monomers for forming structural units of the acrylic acid-based polymer and adding 1% to 50% by mass of a total amount of the hypophosphorous acid compound to a reactor before supplying the monomer. The phosphorous acid ion is contained in an amount of 20 to 1,000 ppm by mass based on a solid content of the acrylic acid-based polymer.
Abstract: The present invention relates to a production method for efficiently obtaining an acrylic acid-based polymer having a narrow molecular mass distribution and a low molecular mass, without using a large amount of chain transfer agent. A method for continuously producing an acrylic acid-based polymer obtained by continuously polymerizing a monomer having acrylic acid as an essential component, characterized in that a liquid feed pump applies a mechanical load of 0.5 to 2.5 kJ/L to the liquid discharged from the outlet of a reactor. An acrylic acid-based polymer having fewer high-molecular-mass components, excellent dispersion and other properties, and a low molecular mass is thereby obtained.
Abstract: A cell growth inhibitor that includes, as an antibody component, an artificially produced anti-EGFR antibody having specific binding capacity to EGFR which is characterized in that an epitope therefor is in a cysteine-rich subdomain 2 (C2 domain) and/or in a ligand-binding domain 1 (L1 domain) among four subdomains contained in the extracellular domain of EGFR.
Type:
Grant
Filed:
June 3, 2011
Date of Patent:
May 12, 2015
Assignees:
Toagosei Co. Ltd., Keio University
Inventors:
Nobuyoshi Shimizu, Atsushi Takayanagi, Tetsuhiko Yoshida
Abstract: A composition including an artificially synthesized antimicrobial peptide that is not present as a mature peptide in nature. The composition includes an artificially synthesized peptide that has an antimicrobial activity against at least one strain of bacteria or fungi and includes an amino acid sequence represented by any one of SEQ ID NOs: 1 to 6 or an amino acid sequence formed by substituting, deleting and/or adding one, two or three amino acid residues in/from/to the amino acid sequence, and further including at least one species of pharmaceutically acceptable carrier.
Abstract: A deodorizing mask includes an air permeable mask main body for covering nose and mouth of the user with at least two types of nonwoven cloth, the mask main body having a deodorizing nonwoven cloth layer including a chemical adsorptive deodorizer and a dustproof nonwoven cloth layer having a dustproof effect, and the air permeability of the dustproof nonwoven cloth layer being ? or less of the air permeability of the deodorizing nonwoven cloth layer. Preferably, the air permeability of the dustproof nonwoven cloth layer is in a range of 10 to 120 cm/(cm·s) in a permeated air quantity based on the Frazir method, the air permeability of the deodorizing nonwoven cloth layer is in a range of 40 to 400 cm/(cm·s) in a permeated air quantity based on the Frazir method, and the permeated air quantity of the dustproof nonwoven cloth layer is ? or less of the permeated air quantity of the deodorizing nonwoven cloth layer.
Abstract: The present invention is a method for producing solvent-soluble polysiloxanes which includes a condensation process of subjecting a raw material having siloxane-bond-forming groups to hydrolytic copolycondensation in the presence of a catalyst to synthesize a reactive polysiloxane represented by general formula (1), the raw material containing both an organosilicon compound (S1) having a (meth)acryloyl group and siloxane-bond-forming groups and at least one silicon compound (S2) selected from among tetraalkoxysilanes and tetrahalogenosilanes, wherein in the condensation process, the organosilicon compound (S1) and silicon compound (S2) are used at a (S2)/(S1) molar ratio of 1.